Year |
Citation |
Score |
2017 |
Zhang X, Cai C, Sui Z, Macielag M, Wang Y, Yan W, Suckow A, Hua H, Bell A, Haug P, Clapper W, Jenkinson C, Gunnet J, Leonard J, Murray WV. Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 Diabetes. Acs Medicinal Chemistry Letters. 8: 947-952. PMID 28947942 DOI: 10.1021/Acsmedchemlett.7B00233 |
0.32 |
|
2017 |
Zhang X, Cai C, Winters M, Wells M, Wall M, Lanter J, Sui Z, Ma J, Novack A, Nashashibi I, Wang Y, Yan W, Suckow A, Hua H, Bell A, et al. Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists. Bioorganic & Medicinal Chemistry Letters. PMID 28642104 DOI: 10.1016/J.Bmcl.2017.06.028 |
0.436 |
|
2014 |
Teleha CA, Branum S, Zhang Y, Reuman ME, Van Der Steen L, Verbeek M, Fawzy N, Leo GC, Kang FA, Cai C, Kolpak M, Beauchamp DA, Wall MJ, Russell RK, Sui Z, et al. Lab-scale preparation of a novel carbocyclic chemokine receptor antagonist Organic Process Research and Development. 18: 1622-1629. DOI: 10.1021/Op500265Z |
0.428 |
|
2013 |
Cai C, Kang FA, Hou C, O'Neill JC, Opas E, McKenney S, Johnson D, Sui Z. Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 23: 351-4. PMID 23182090 DOI: 10.1016/J.Bmcl.2012.10.069 |
0.337 |
|
2013 |
Cai C, Kang F, Beauchamp DA, Sui Z, Russell RK, Teleha CA. Chiral aminocyclopentene-based cycloaddition strategies to bicyclic [3.3.0] rings Tetrahedron: Asymmetry. 24: 651-656. DOI: 10.1016/J.Tetasy.2013.04.014 |
0.374 |
|
2012 |
Breslin HJ, Diamond CJ, Kavash RW, Cai C, Dyatkin AB, Miskowski TA, Zhang SP, Wade PR, Hornby PJ, He W. Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d). Bioorganic & Medicinal Chemistry Letters. 22: 4869-72. PMID 22695132 DOI: 10.1016/J.Bmcl.2012.05.042 |
0.319 |
|
2011 |
Zhang X, Hufnagel H, Markotan T, Lanter J, Cai C, Hou C, Singer M, Opas E, McKenney S, Crysler C, Johnson D, Sui Z. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21: 5577-82. PMID 21783361 DOI: 10.1016/J.Bmcl.2011.06.080 |
0.312 |
|
2010 |
Soloshonok VA, Cai C, Hruby VJ. ChemInform Abstract: (S)- or (R)-3-(E-Enoyl)-4-phenyl-1,3-oxazolidin-2-ones: Ideal Michael Acceptors to Afford a Virtually Complete Control of Simple and Face Diastereoselectivity in Addition Reactions with Glycine Derivatives. Cheminform. 31: no-no. DOI: 10.1002/chin.200027129 |
0.441 |
|
2010 |
Soloshonok VA, Cai C, Hruby VJ. ChemInform Abstract: Asymmetric Michael Addition Reactions of Chiral Ni(II)-Complex of Glycine with (N-trans-Enoyl)oxazolidines: Improved Reactivity and Stereochemical Outcome. Cheminform. 31: no-no. DOI: 10.1002/chin.200012189 |
0.425 |
|
2010 |
HAN Y, LIAO S, QIU W, CAI C, HRUBY VJ. ChemInform Abstract: Total Asymmetric Synthesis of Highly Constrained Amino Acids β- Isopropyl-2′,6′-dimethyl-tyrosines. Cheminform. 28: no-no. DOI: 10.1002/chin.199743204 |
0.446 |
|
2006 |
Breslin HJ, Cai C, Miskowski TA, Coutinho SV, Zhang SP, Hornby P, He W. Identification of potent phenyl imidazoles as opioid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16: 2505-8. PMID 16483774 DOI: 10.1016/J.Bmcl.2006.01.082 |
0.329 |
|
2005 |
Soloshonok VA, Cai C, Yamada T, Ueki H, Ohfune Y, Hruby VJ. Michael addition reactions between chiral equivalents of a nucleophilic glycine and (S)- or (R)-3-[(E)-enoyl]-4-phenyl-1,3-oxazolidin-2-ones as a general method for efficient preparation of beta-substituted pyroglutamic acids. Case of topographically controlled stereoselectivity. Journal of the American Chemical Society. 127: 15296-303. PMID 16248672 DOI: 10.1021/Ja0535561 |
0.592 |
|
2005 |
Cai C, Breslin HJ, He W. A convenient, large-scale synthesis of 4′-carboxamido N-Boc-2′,6′-dimethyl-l-phenylalanines Tetrahedron. 61: 6836-6838. DOI: 10.1016/J.Tet.2005.04.065 |
0.351 |
|
2004 |
Soloshonok VA, Ueki H, Tiwari R, Cai C, Hruby VJ. Virtually complete control of simple and face diastereoselectivity in the Michael addition reactions between achiral equivalents of a nucleophilic glycine and (S)- or (R)-3-(E-enoyl)-4-phenyl-1,3-oxazolidin-2-ones: practical method for preparation of beta-substituted pyroglutamic acids and prolines. The Journal of Organic Chemistry. 69: 4984-90. PMID 15255725 DOI: 10.1021/Jo0495438 |
0.603 |
|
2004 |
Cai M, Cai C, Mayorov AV, Xiong C, Cabello CM, Soloshonok VA, Swift JR, Trivedi D, Hruby VJ. Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to human MC5 receptor selectivity. The Journal of Peptide Research : Official Journal of the American Peptide Society. 63: 116-31. PMID 15009533 DOI: 10.1111/J.1399-3011.2003.00105.X |
0.693 |
|
2004 |
Cai C, Yamada T, Tiwari R, Hruby VJ, Soloshonok VA. Application of (S)- and (R)-methyl pyroglutamates as inexpensive, yet highly efficient chiral auxiliaries in the asymmetric Michael addition reactions Tetrahedron Letters. 45: 6855-6858. DOI: 10.1016/J.Tetlet.2004.07.096 |
0.573 |
|
2003 |
Soloshonok VA, Ueki H, Jiang C, Cai C, Hruby VJ. A Convenient, Room-Temperature — Organic Base Protocol for Preparing Chiral 3-(Enoyl)-1,3-oxazolidin-2-ones. Cheminform. 34. DOI: 10.1002/1522-2675(200211)85:11<3616::Aid-Hlca3616>3.0.Co;2-O |
0.503 |
|
2002 |
Wang W, Yang J, Ying J, Xiong C, Zhang J, Cai C, Hruby VJ. Stereoselective synthesis of dipeptide beta-turn mimetics: 7-benzyl and 8-phenyl substituted azabicyclo[4.3.0]nonane amino acid esters. The Journal of Organic Chemistry. 67: 6353-60. PMID 12201753 DOI: 10.1021/Jo0203591 |
0.719 |
|
2002 |
Xiong C, Wang W, Cai C, Hruby VJ. Regioselective and stereoselective nucleophilic ring opening reactions of a phenyl-substituted aziridine: enantioselective synthesis of beta-substituted tryptophan, cysteine, and serine derivatives. The Journal of Organic Chemistry. 67: 1399-402. PMID 11846696 DOI: 10.1021/Jo010860D |
0.668 |
|
2002 |
Hruby VJ, Agnes RS, Cai C. Design of peptide agonists. Methods in Enzymology. 343: 73-91. PMID 11665596 DOI: 10.1016/S0076-6879(02)43128-X |
0.682 |
|
2002 |
Soloshonok V, Ueki H, Jiang C, Cai C, Hruby V. A Convenient, Room-Temperature–Organic Base Protocol for Preparing Chiral 3-(Enoyl)-1,3-oxazolidin-2-ones Helvetica Chimica Acta. 85: 3616-3623. DOI: 10.1002/1522-2675(200211)85:11<3616::AID-HLCA3616>3.0.CO;2-O |
0.396 |
|
2001 |
Cai C, Soloshonok VA, Hruby VJ. Michael addition reactions between chiral Ni(II) complex of glycine and 3-(trans-enoyl)oxazolidin-2-ones. A case of electron donor-acceptor attractive interaction-controlled face diastereoselectivity. The Journal of Organic Chemistry. 66: 1339-50. PMID 11312965 DOI: 10.1021/Jo0014865 |
0.559 |
|
2000 |
Soloshonok VA, Cai C, Hruby VJ, Van Meervelt L, Yamazaki T. Rational design of highly diastereoselective, organic base-catalyzed, room-temperature Michael addition reactions. The Journal of Organic Chemistry. 65: 6688-96. PMID 11052120 DOI: 10.1021/Jo0008791 |
0.566 |
|
2000 |
Soloshonok VA, Cai C, Hruby VJ. A Practical Asymmetric Synthesis of Enantiomerically Pure 3-Substituted Pyroglutamic Acids and Related Compounds This work was supported by grants from the U.S. Public Health Service (Grant DK 17420) and the National Institute of Drug Abuse (DA 06284 and DA 04248). The views expressed are those of the authors and not necessarily those of the USPHS. Angewandte Chemie (International Ed. in English). 39: 2172-2175. PMID 10941052 DOI: 10.1002/1521-3773(20000616)39:12<2172::Aid-Anie2172>3.0.Co;2-0 |
0.454 |
|
2000 |
Soloshonok VA, Cai C, Hruby VJ. (S)- or (R)-3-(E-enoyl)-4-phenyl-1,3-oxazolidin-2-ones: ideal Michael acceptors to afford a virtually complete control of simple and face diastereoselectivity in addition reactions with glycine derivatives. Organic Letters. 2: 747-50. PMID 10754676 DOI: 10.1021/Ol990402F |
0.525 |
|
2000 |
Soloshonok VA, Cai C, Hruby VJ. Toward design of a practical methodology for stereocontrolled synthesis of χ-constrained pyroglutamic acids and related compounds. Virtually complete control of simple diastereoselectivity in the Michael addition reactions of glycine Ni(II) complexes with N-(enoyl)oxazolidinones Tetrahedron Letters. 41: 135-139. DOI: 10.1016/S0040-4039(99)02018-3 |
0.573 |
|
2000 |
Soloshonok* VA, Cai C, Hruby VJ. A unique case of face diastereoselectivity in the Michael addition reactions between Ni(II)-complexes of glycine and chiral 3-(E-enoyl)-1,3-oxazolidin-2-ones Tetrahedron Letters. 41: 9645-9649. DOI: 10.1016/S0040-4039(00)01737-8 |
0.494 |
|
2000 |
Qiu W, Soloshonok VA, Cai C, Tang X, Hruby VJ. Convenient, Large-Scale Asymmetric Synthesis of Enantiomerically Pure trans-Cinnamylglycine and -α-Alanine Tetrahedron. 56: 2577-2582. DOI: 10.1016/S0040-4020(00)00176-9 |
0.611 |
|
2000 |
Soloshonok VA, Cai C, Hruby VJ. ChemInform Abstract: A Practical Asymmetric Synthesis of Enantiomerically Pure 3-Substituted Pyroglutamic Acids and Related Compounds. Cheminform. 31: no-no. DOI: 10.1002/chin.200040108 |
0.477 |
|
1999 |
Soloshonok VA, Cai C, Hruby VJ. Asymmetric Michael addition reactions of chiral Ni(II)-complex of glycine with (N-trans-enoyl)oxazolidines: Improved reactivity and stereochemical outcome Tetrahedron Asymmetry. 10: 4265-4269. DOI: 10.1016/S0957-4166(99)00483-8 |
0.556 |
|
1999 |
Soloshonok VA, Cai C, Hruby VJ, Van Meervelt L, Mischenko N. Stereochemically defined C-substituted glutamic acids and their derivatives. 1. An efficient asymmetric synthesis of (2S,3S)-3-methyl- and -3-trifluoromethylpyroglutamic acids Tetrahedron. 55: 12031-12044. DOI: 10.1016/S0040-4020(99)00711-5 |
0.572 |
|
1999 |
Soloshonok VA, Cai C, Hruby VJ, Van Meervelt L. Asymmetric synthesis of novel highly sterically constrained (2S,3S)-3-methyl-3-trifluoromethyl- and (2S,3S,4R)-3-trifluoromethyl-4-methylpyroglutamic acids Tetrahedron. 55: 12045-12058. DOI: 10.1016/S0040-4020(99)00710-3 |
0.55 |
|
1997 |
Han Y, Liao S, Qiu W, Cai C, Hruby VJ. Total asymmetric synthesis of highly constrained amino acids β-isopropyl-2′,6′-dimethyl-tyrosines Tetrahedron Letters. 38: 5135-5138. DOI: 10.1016/S0040-4039(97)01094-0 |
0.601 |
|
Show low-probability matches. |